Search Result "relative risk ratio"
Quantifying Risk: The Role of Absolute and Relative Measures in Interpreting Risk of Adverse Reactions from Product Labels of Antipsychotic Medications
Journal: Current Drug Safety
Volume: 4 Issue: 3 Year: 2009 Page: 229-237
Author(s): Leslie Citrome
Urine Albumin/Creatinine Ratio, High Sensitivity C-Reactive Protein and N-Terminal Pro Brain Natriuretic Peptide - Three New Cardiovascular Risk Markers - Do They Improve Risk Prediction and Influence Treatment?
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 1 Year: 2010 Page: 134-139
Author(s): Michael H. Olsen, Thomas Sehestedt, Stig Lyngbaek, Tine W. Hansen, Susanne Rasmussen, Kristian Wachtell, Christian Torp-Pedersen, Per R. Hildebrandt, Hans Ibsen
Increased Neutrophil-to-lymphocyte Ratios are Associated with Greater Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Journal: Current Neurovascular Research
Volume: 15 Issue: 4 Year: 2018 Page: 326-335
Author(s): Quhong Song,Yisong Li,Yanan Wang,Chenchen Wei,Junfeng Liu,Ming Liu
The Ultra High Risk Approach to Define Psychosis Risk
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 346-350
Author(s): Alison R. Yung, Paolo Fusar-Poli, Barnaby Nelson
Evaluation of the Risk/Benefit Ratio of Old and New Anti-Inflammatory Drugs
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5 Issue: 4 Year: 2006 Page: 335-352
Author(s): P. F. Mannaioni, V. Fabbroni, R. Mastroianni, E. Masini
Risk Stratification of Dyslipidemia: Insights from the Framingham Study
Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 3 Issue: 3 Year: 2005 Page: 187-193
Author(s): W. B. Kannel
Evaluation of TG-HDL Ratio Instead of HOMA Ratio as Insulin Resistance Marker in Overweight and Children with Obesity
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19 Issue: 5 Year: 2019 Page: 676-682
Author(s): Eman G. Behiry,Nazih Mohamed El Nady,Omima M. AbdEl Haie,May Kamel Mattar,Amira Magdy
Apolipoprotein B and Apolipopotein A-I in Vascular Risk Prediction-A Review
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6289-6298
Author(s): C. Schmidt, G. Bergstrom
Glycemic Control and CKD: Evaluation of the Risk/Benefit Ratio: Optimal Therapeutic Strategies
Ebook: Diabetes: Current and Future Developments
Volume: 1 Year: 2020
Author(s): Gül Bahtiyar,Harold Lebovitz,Alan Sacerdote
Doi: 10.2174/9789811422003120010014
The Economic Costs for the Control of Cardiovascular Risk: An Overview
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2447-2453
Author(s): Aldo Leone